The Weekly Season 1 Episode 14 V. Johnson & Johnson

The Weekly season 1 episode 14, titled "V. Johnson & Johnson," is an investigative look into the legal battle between pharmaceutical giant Johnson & Johnson and the state of Oklahoma over the opioid crisis. The episode follows the trial proceedings, which saw the state seeking $17 billion in damages from Johnson & Johnson for their alleged role in fueling the opioid epidemic through deceptive marketing practices.

The episode is anchored by New York Times reporter Barry Meier, who has been covering the opioid epidemic for years. Meier provides context for the case, highlighting the devastating toll that the opioid crisis has taken on communities across the country.

The Oklahoma trial is a high-stakes battle that could reverberate across the pharmaceutical industry. The state argues that Johnson & Johnson's aggressive marketing tactics, which allegedly downplayed the risks of opioids and exaggerated their benefits, contributed to the widespread addiction and overdose deaths that have ravaged communities in Oklahoma and beyond.

Meier speaks to a range of experts to explore the legal and ethical questions at the heart of the case. He interviews a former FDA official who argues that Johnson & Johnson's marketing practices were tantamount to fraud, as well as a lawyer representing the company who defends their actions as lawful and ethical.

The episode examines the evidence presented in the trial, which includes internal company documents and memos that paint a damning picture of Johnson & Johnson's marketing tactics. Meier also speaks to families who have been affected by the opioid crisis, including a mother whose son died of an overdose after being prescribed opioids for a sports injury.

As the trial progresses, tensions rise and the stakes become higher. Johnson & Johnson argues that they are being unfairly blamed for a crisis that has multiple causes, including the actions of illegal drug dealers and doctors who overprescribed opioids. The company also highlights their role in developing alternative pain medications and investing in addiction treatment.

The episode provides a nuanced perspective on the opioid crisis, exploring the complex factors that have contributed to the epidemic. It also raises important questions about the responsibility of pharmaceutical companies and the role of regulation in preventing future crises.

Overall, "V. Johnson & Johnson" is a powerful and timely episode that sheds light on one of the most pressing public health challenges of our time. It is a must-watch for anyone interested in understanding the roots of the opioid crisis and the potential for legal action to hold those responsible accountable.